BioLizard launches new BioVerse Platform to accelerate life sciences R&D processes

BioLizard, the bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life sciences industry, today announced the launch of its new BioVerse platform.

Long-Term Data in Frontline RCC Raise More Questions Than Answers

At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported long-term updates from various phase III trials on first-line treatment options for advanced

June 28, 2023

Access to new tools to combat RSV in babies likely to prove challenging

In a fall in which new tools to fight old diseases — updated Covid-19 vaccines, new products to protect older adults and babies from RSV

October 6, 2023

Health tech investments are picking up steam. Here are 5 VC leaders behind the biggest recent deals

Health tech investments are showing signs of resilience following the perilous lows of 2022 and 2023: Just this past month, two startups that analysts believe

October 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.